CREST Update, September 2022
Features include:
-
Using choice to understand preferences to undertake polygenic risk scores tests to estimate cancer risk (CHERE)
-
Australasian Gastro-Intestinal Trials Group (AGITG)
-
Australia New Zealand Gynaecological Oncology Group (ANZGOG)
-
Australia and New Zealand Sarcoma Association (ANZSA)
-
Cancer Quality of Life Expert Service Team (CQUEST)
- Upcoming Workshop: Choosing patient reported outcome measures (PROM) for cancer clinical research, 12th October @5pm (Zoom)
-
An Australia first: Best-practice bundle for private breast cancer treatment (Paying for Value)
-
Australian & New Zealand Urogenital and Prostate (ANZUP)
- Upcoming workshops: Best of GU Oncology Evening Symposium, 9th November (Melbourne); and Prostate Cancer Rapid Fire Program, 18-19 November (Sydney)
-
Breast Cancer Trials (BCT)
-
Cancer Symptom Trials (CST)
-
Melanoma and Skin Cancer trials (MASC)
-
Psycho-oncology Co-operative Research Group (PoCoG)
-
Quality of life in survivors of breast cancer once, three and five years post-diagnosis
-
Australasian Leukaemia & Lymphoma Group (ALLG)
-
Trans Tasman Radiation Oncology Group (TROG)
-
CREST Health Economics Workshop
-
Health Technology Assessment Webinar Series
-
Understanding health economics in Cancer Research, 18th November (Zoom)
-
-
CREST Monthly Drop-In Health Economics Clinics
